BCK Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

BCK Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,000	Closed	-$933K	–	88
2023 Q4	$933K	Buy	+15,000	New	+$373K	0.91%	35

BCK Capital Management's RYZB Position: Q1 2024 in Review

BCK Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 15,000 shares — an estimated $933K sold.

BCK Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $933K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

BCK Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
BCK Capital Management sold 15,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $933K.
BCK Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
BCK Capital Management's RayzeBio, Inc. Common Stock position peaked at $933K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on BCK Capital Management's 13F filing for Q1 2024, filed 8 May 2024.